Table 1 General characteristics.
Characteristics | All participants (n = 190) | Participants with beta-blocker prescription (n = 105) | Participants without beta-blocker prescription (n = 85) | p value |
---|---|---|---|---|
Age (years) | 75.50 ± 9.05 | 73.92 ± 8.87 | 77.45 ± 8.93 | 0.007 |
Sex | ||||
Male | 101 (53.2%) | 50 (47.6%) | 51 (60%) | 0.089 |
Female | 89 (46.8%) | 55 (52.4%) | 34 (40%) | |
Smoking | 12 (6.3%) | 7 (6.7%) | 5 (5.9%) | 0.825 |
Body mass index | ||||
Normal | 96 (50.5%) | 56 (53.3%) | 40 (47.1%) | 0.606 |
Underweight | 33 (17.4%) | 15 (14.3%) | 18 (21.2%) | |
Overweight | 32 (16.8%) | 17 (16.2%) | 15 (17.6%) | |
Obese | 29 (15.3%) | 17 (16.2%) | 12 (14.1%) | |
NYHA classes on admission | ||||
NYHA I | 0 | 0 | 0 | 0.287 |
NYHA II | 61 (32.1%) | 34 (32.4%) | 27 (31.8%) | |
NYHA III | 127 (66.8%) | 71 (67.6%) | 56 (65.9%) | |
NYHA IV | 2 (1.1%) | 0 (0%) | 2 (2.4%) | |
Hypertension | 159 (83.7%) | 91 (86.7%) | 68 (80%) | 0.216 |
Ischemic heart disease | 153 (80.5%) | 88 (83.8%) | 65 (76.5%) | 0.204 |
Diabetes | 67 (35.3%) | 37 (35.2%) | 30 (35.3%) | 0.994 |
Dyslipidemia | 66 (34.7%) | 38 (36.2%) | 28 (32.9%) | 0.640 |
Atrial fibrillation | 60 (31.6%) | 31 (29.5%) | 29 (34.1%) | 0.498 |
Chronic kidney disease | 47 (24.7%) | 16 (15.2%) | 31 (36.5%) | < 0.001 |
Valvular heart disease | 18 (9.5%) | 11 (10.5%) | 7 (8.2%) | 0.600 |
Chronic obstructive pulmonary disease | 13 (6.8%) | 2 (1.9%) | 11 (12.9%) | 0.003 |
Dilated Cardiomyopathy | 9 (4.7%) | 4 (3.8%) | 5 (5.9%) | 0.504 |
Heart rate on admission (beat per minute) | 84.65 ± 3.61 | 86.27 ± 15.74 | 82.65 ± 17.60 | 0.137 |
Systolic blood pressure on admission (mmHg) | 126.44 ± 12.81 | 125.81 ± 16.83 | 127.22 ± 19.02 | 0.588 |
Diastolic blood pressure on admission (mmHg) | 75.76 ± 9.77 | 75.47 ± 9.10 | 76.12 ± 10.59 | 0.649 |
Serum NT-proBNP level on admission (pg/mL) | 5270.72 ± 7723.46 | 3669.45 ± 5113.77 | 7248.76 ± 9730.11 | 0.003 |
Serum creatinine on admission (mcmol/l) | 129.85 ± 61.33 | 118.15 ± 60.84 | 144.37 ± 59.13 | 0.003 |
eGFR on admission (mL/min/1.73m2) | 52.44 ± 19. 77 | 57.17 ± 18.62 | 46.60 ± 19.70 | < 0.001 |
PAPs on admission (mmHg) | 33.82 ± 14.25 | 32.76 ± 13.95 | 35.13 ± 14.58 | 0.256 |
LVEF on admission (%) | 50.74 ± 15.06 | 50.44 ± 13.83 | 51.12 ± 16.53 | 0.758 |